Workflow
隐形眼镜
icon
Search documents
甘肃税务:激活企业创新的“源头活水”
Sou Hu Cai Jing· 2025-07-11 07:52
甘肃省税务局聚焦高新技术企业、"专精特新"企业、科技型中小企业等重点群体,为企业提供"零距离"政策辅导、"全周期"政策服务、"动态化"风险预警, 以税费优惠政策的精准落实、服务质效的不断提升、涉税风险的有效防范,为企业发展注入科技创新的"源头活水"。 张掖市临泽县奋君矿业有限公司是一家集凹凸棒石、石膏等非金属矿石生产、科研、工程设计于一体的科技型民营企业。近年来,公司加快了凹凸棒石产品 研发的步伐,企业研发投入也水涨船高。"在税务干部的精准辅导下,我们今年享受研发费用加计扣除32万元,有了更多流动资金进行新设备研发。"公司财 务人员李秀芬说。 "全周期"税费服务 打通落实堵点 "零距离"政策辅导 推进红利直达 创新是引领发展的第一动力。为助力市场主体更好启动科技创新"新引擎",甘肃省税务部门持续完善税费政策精准送达机制,以"零距离"的政策辅导及时将 政策红利送达纳税人,持续跟踪政策落实情况,帮助企业应享快享、应享尽享,释放"政策找人"效能,不断激发企业革新技术的内生动力。 在玉门经济开发区甘肃凯盛大明光能科技有限公司的生产车间里,一块玻璃从原料到成品的"诞生"正在上演。随着全球首条全氧燃烧工艺生产光热超白浮法 ...
股市必读:迈得医疗(688310)7月8日主力资金净流入756.81万元,占总成交额13.96%
Sou Hu Cai Jing· 2025-07-08 20:06
截至2025年7月8日收盘,迈得医疗(688310)报收于16.17元,上涨3.52%,换手率2.04%,成交量3.4万 手,成交额5420.36万元。 迈得医疗工业设备股份有限公司第五届监事会第二次会议于2025年7月7日召开,会议审议并通过了《关 于控股子公司增资暨关联交易的议案》。监事会认为此次增资暨关联交易有利于满足控股子公司浙江迈 得顺隐形眼镜有限公司的资金需求,推进其业务发展,增强可持续发展能力,同时与优秀人才利益捆 绑,调动公司核心骨干人员的积极性,促进协同发展。交易定价公允合理,决策程序符合有关法律法规 和公司章程的规定,不影响公司独立性,不会对公司财务和经营产生不利影响,不存在损害公司及全体 股东特别是中小股东利益的情形。表决结果为同意2票,反对0票,弃权0票,关联监事陈君回避表决。 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 交易信息汇总:7月8日主力资金净流入756.81万元,占总成交额13.96%。 公司公告汇总:第五届监事会第二次会议审议通过了关于控股子公司增资暨关联交易的议案,旨 在满足浙江迈得顺隐形 ...
迈得医疗业绩断崖式下跌 存货减值是否埋雷
Xin Lang Zheng Quan· 2025-07-04 09:23
Core Viewpoint - The company, Maide Medical, is facing a significant decline in revenue and market challenges, particularly in its core safety infusion equipment segment, leading to concerns about its financial health and future prospects [2][3][4]. Revenue Performance - In 2024, Maide Medical's revenue plummeted by 42.77% year-on-year, totaling 275 million yuan, with core products experiencing substantial declines: safety infusion equipment revenue fell by 39.59%, and blood purification equipment revenue dropped to zero [2]. - The overall market for injection and puncture consumables in China shrank by 2.57% to 32 billion yuan, exacerbated by external pressures such as the FDA's safety reviews and tariffs on Chinese syringes [2]. Product Performance - The only bright spot was a 67.12% increase in revenue from blood purification connection machines, reaching 104 million yuan, although the average price halved from 20.78 million yuan to 8.01 million yuan [3]. - The shift towards lower-tier products in response to market demands raises concerns about the loss of technical premium and profitability [3]. Customer Concentration and Risks - The concentration of revenue among the top five customers increased, with the largest customer, Sanxin Medical, accounting for 32.65% of revenue (89.74 million yuan) and related transactions comprising 12.41% [3]. - The long repayment cycle of 1-3 years for major clients highlights potential liquidity risks for the company [3]. New Business Ventures - To counteract the decline in traditional business, Maide Medical is venturing into contact lens manufacturing through its subsidiary, Maide Shun, although this new business is currently in a cash-burning phase [4]. - Management expenses rose to 95 million yuan, and R&D expenses increased by 21.81% to 40 million yuan, with long-term loans of 30 million yuan fully invested in this new area [4]. Financial Health Indicators - Financial indicators are raising red flags, with inventory valued at 139 million yuan, constituting 22.99% of current assets, and a significant increase in contract liabilities by 78.59% to 98.84 million yuan [4]. - The company reported a goodwill impairment of 10.42 million yuan and a doubling of construction in progress to 50.01 million yuan, indicating potential asset bubble concerns [4].
眼睛看一会儿手机就模糊?你可能患上了干眼症 自测一下
Yang Shi Xin Wen· 2025-07-04 07:44
Core Viewpoint - Dry eye syndrome is a common eye condition affecting one in three people in China, often exacerbated by daily habits and environmental factors [2][15]. Group 1: Symptoms of Dry Eye Syndrome - Typical symptoms include dryness, foreign body sensation, burning or stinging, and eye fatigue [4][5][6][7]. - Visual symptoms consist of blurred vision, light sensitivity, and temporary vision fluctuations [8][9][10]. - Other accompanying symptoms may include redness, increased tearing, and difficulty wearing contact lenses [10][11]. Group 2: Risks and Complications - Long-term dry eye can lead to permanent vision damage, decreased quality of life, increased risk of infections, and exacerbation of other eye diseases [15][17][18][19]. - Chronic inflammation and eye surface damage can create a vicious cycle, making treatment more difficult [19]. Group 3: Causes and Contributing Factors - Dry eye syndrome has complex causes, including age, autoimmune diseases, medication effects, and environmental factors [21]. - Poor eye habits, such as prolonged contact lens wear, excessive screen time, and improper use of eye drops, significantly contribute to the condition [21][22][23][24]. Group 4: Prevention and Management Strategies - Recommended strategies include the 20-20-20-2 rule, adjusting screen height, and using warm compresses to improve blood circulation [26][27]. - Dietary adjustments, such as increasing intake of unsaturated fatty acids and vitamins, are also suggested to support eye health [27].
迈得医疗: 天健会计师事务所(特殊普通合伙)关于迈得医疗工业设备股份有限公司2024年年度报告的信息披露监管问询函的专项说明
Zheng Quan Zhi Xing· 2025-07-03 16:27
Main Business - The company's main products include safety infusion devices and blood purification equipment, with significant revenue declines in safety infusion single machines and blood purification single machines, down 39.59% and 100.00% respectively, while blood purification continuous machines saw substantial growth [2][5][6] - The first major customer accounted for a significant portion of annual sales, with the increase in transaction amount attributed to the growth in the blood purification product business and the overall industry [2][14] Supplier Information - The company sources all standard parts externally, with a mix of self-manufactured, custom procurement, and outsourced processing for non-standard components. The total procurement amount for 2024 was 23,959.42 million yuan, a decrease of 36.99% compared to the previous year [28][29] Inventory and Contract Liabilities - The company reported that the inventory of blood purification single machines remained unsold due to production cycle delays and customer facility issues, impacting revenue recognition [11][12] - The company maintains a production model based on order fulfillment, which has led to fluctuations in sales revenue for blood purification single machines [11][12] Accounts Receivable and Long-term Receivables - The company provided details on its top five customers, including transaction amounts and payment conditions, indicating a healthy receivables situation with good recovery rates [13][15] Goodwill Impairment - There were no indications of impairment for the company's assets, as the net realizable value of blood purification single machines exceeded their costs, negating the need for inventory write-downs [12][25] Construction in Progress - The company has invested in the development of its contact lens manufacturing subsidiary, with a focus on material research and production line construction, indicating a strategic expansion into the optical sector [3][24] Market Trends - The blood dialysis medical device market in China is projected to grow steadily, with a compound annual growth rate of 5.67% from 2019 to 2023, expected to reach 51.515 billion yuan by 2030 [6][14] - The company is also expanding into the contact lens market, which is anticipated to grow significantly, with the transparent and colored contact lens markets projected to reach 161 billion yuan and 183 billion yuan respectively by 2030 [18][20]
创新白银 收获真金 粤港澳大湾区主流媒体记者采访团走进甘肃白银
Shen Zhen Shang Bao· 2025-06-28 16:45
近日,粤港澳大湾区主流媒体记者采访团结束了白银之旅。记者们以生动的笔触和镜头全面展示了白银 市在新时代所展现的全新面貌。 白银市的工业发展十分注重创新与研发。白银有色长通电线电缆有限责任公司是西北地区经营历史最久 的集研发、生产、销售于一体的综合性电线电缆企业。近年来,公司建立了以中国工程院李建刚院士及 其团队为核心的超导电缆工程实验室;承担了省、市科技重大专项和科技支撑计划项目十余项;专利拥 有量近百件。公司主导产品为低温超导电缆、微细及超微细电磁线、特种电缆、电力电缆等,主要应用 在国内外重大工程项目上及电子元器件、智能控制等行业。微细及超微细电磁线产品出口日本、印度、 泰国、越南等国家。公司年生产规模达15亿元。 与长通电缆相比,白银时代瑞象新材料科技有限公司则是一家新公司,成立于2022年10月。首期年产2 万吨磷酸锰铁锂正极材料项目刚刚于2025年4月竣工投产,达到全国单体规模产能第一,产品性能处于 行业领先水平。 在农业方面,白银市通过建立新型生产关系,促进新质生产力发展。白银区现代农业科技示范园采 取"园区+公司+农户"模式,以科研机构为支撑,构建现代农业新生态。园区总规划面积达1.5万亩,涵 ...
新一轮融资!国产眼底设备公司完成C轮
思宇MedTech· 2025-06-25 09:06
即将召开: 2025年7月17日,第二届全球医疗科技大会 2025年9月3-5日,第三届全球手术机器人大会 在中国高端眼科设备格局尚未完全打开之际,一项源自天文观测的光学技术,正在被一家中国医疗科技企业带 入诊疗一线。 近日, 南京博视医疗科技有限公司 (简称:博视医疗) 宣布 完成 C轮融资 ,投资方包括南京新工投资、欧 普康视与泰煜投资,具体融资金额未披露。 本轮融资将用于公司在眼科诊疗设备领域的产品迭代、市场拓展 和全球化布局 。 博视医疗成立于2017年,核心团队具备国际眼科影像工程背景, 长期专注于将 光学工程、自适应光学、人眼 追踪与AI算法融合应用于眼科设备 开发。 思宇年度活动回顾: 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 | 首届全球医美科技大会 此次融资延续了公司在2024年底启动的全球商业化进程。早在一个月前的 ARVO 2025年会 期间,博视医疗 自 适应光学眼底影像系统 "星镜 ® " 获得超过800万美元的意向订 单 ,成为国产眼科高端设备出海的重要信号之 一。 # 自适应光学的革命性跨界 起源于天文观测领域的自适应光学(Adaptive Optics, ...
创新白银 收获真金
Sou Hu Cai Jing· 2025-06-24 18:09
深圳商报•读创客户端记者 袁承咏 文/图/视频 6月24日,粤港澳大湾区主流媒体记者采访团结束了白银之旅。记者们以生动的笔触和镜头全面的展示 了白银市在新时代所展现的全新面貌。 记者团首先来到景泰县。这里的黄河石林闻名遐迩,总面积约50平方公里,其中古石林群10平方公里。 进入石林,放眼望去,嶙峋岩柱高耸入云,峡谷曲折。不愧是甘肃省地质遗迹自然保护区、国家地质公 园、国家AAAA级景区。 白银十分重视文旅产业的发展,黄河石林是其中的亮点之一。据介绍,2024年白银市接待游客总量达 3443.22万人次,同比增长42.44%;实现旅游收入207.04亿元,增长64.5%,文旅融合正成为该地推动经 济高质量发展的新引擎。 随后记者一行走进甘肃康视丽隐形眼镜有限公司生产基地。这是白银市规模最大的民营企业,主营各类 隐形眼镜,其产品占国内隐形眼镜的半壁江山,是当地推动科技产业转型的重点项目之一。 总经理唐钰喜介绍,近年来,企业通过研发创新的拳头产品湿润性与透氧性能显著提升,达到同行业的 一流水平。公司投产的全自动化智能生产线已实现彩印、成型、检测等工艺数字化集成,结合AGV机 器人系统,完全做到了重要生产环节无人化。 ...
铜城“智变”:甘肃白银产业转型的科技密码与田园新诗
Sou Hu Cai Jing· 2025-06-24 17:24
从铜矿枯竭的忧虑到新兴产业的星火燎原,甘肃白银这座老工业城市,正悄然书写着黄土地上的创新传奇。 6月23日、24日,第六届粤港澳大湾区主流媒体甘肃行活动走进白银市,羊城晚报记者历时两天走访白银市多处产业现场,从洁净的隐形眼镜全自动化车 间、轰鸣的超导电缆生产线,到青烟袅袅的古法砖窑、生机盎然的现代化农业科技示范园,一幅老工业城市"破茧蝶变"的生动图景徐徐展开。 E THE THE 21.00 e production - 12 1118 n f 【 nt an 1977 10 gradia a TTCTST b 3 e n ] 白银的电池新材料产业集群正在加速形成。时代瑞象规划建设年产10万吨锰基正极材料产业基地,该公司相关负责人习先生介绍,首期年产2万吨磷酸锰铁 锂正极材料项目已于今年4月竣工投产,达到全国单体规模产能第一。该公司联合高校及科研机构建立"产学研"平台,上下游产业链方面,与供应商和客户 合作,形成锂电产业集群。 在白银有色长通电线电缆有限责任公司内,技术人员向记者展示了该公司的最新产品,一款直径0.012毫米的超微细电磁线,仅为男性头发丝直径的五分之 一,达到了国内极限制造水平。这家始建于19 ...
获批上市!又一款国产自主研发软镜
思宇MedTech· 2025-06-10 09:54
思宇年度活动回顾: 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 即将召开: 据介绍,路得瞳是博视医疗旗下 全自主5S软性接触镜制造商 ,即自研材料、自创设计、自制模具、自造设 备、自主生产。旗下多种水凝胶和硅水凝胶材料,融合高透氧性、高柔软性、高水润性和高保湿性, 打破国 外对硅水凝胶镜片材料及量产工艺技术的垄断 。 # 注册证详情 结构及组成/主要组成成分 : 该产品为增强着色的日戴型软性亲水接触镜。由HEMA、NVP等聚合而成,添加着色剂,聚丙烯杯包装。含水 量标称值:43%。推荐更换周期为1个月。产品经湿热灭菌,货架有效期5年。 2025年6月12日,首届全球医美科技大会 2025年7月17日,第二届全球医疗科技大会 2025年9月4-5日,第三届全球手术机器人大会 近日, 南京博视医疗科技有限公司(简称:"博视医疗") 旗下视力保健产品业务品牌 路得瞳 宣布, 其自主 研发的 月抛彩色隐形眼镜 正式获得国家药品监督管理局(NMPA)注册认证 , 注册证编号为国械注准 20253161016。这是路得瞳 首款 获国家药品监督管理局认证的自主研发软镜。 2020年以来,彩片注册审批周期 ...